1. Unit startpage
  2. Employees
  3. Mona Irene Pedersen
Bilde av Pedersen, Mona Irene
Bilde av Pedersen, Mona Irene
Department of Clinical Medicine mona.i.pedersen@uit.no +4777646317 Tromsø You can find me here

Mona Irene Pedersen

Job description

Mine faglige kompetansefelt er immunhistokjemi (IHC protein) og in situ hybridisering (ISH microRNA og mRNA) hvor vi påviser biomarkører som har relevans innenfor kreftforskningen.

Ansvarsområder:

-  Laboratoriekontakt,  Drift av laboratoriet mht innkjøp, vedlikehold av utstyr etc. Kontaktledd til ledelse og driftsavdeling.

-  Stoffkartotekkontakt, Oppfølging av gruppas HMS arbeid i forhold til stoffkartotek, risikovurderinger og avfallshåndtering.  Kontaktledd til ledelse og øvrige HMS ansvarlige.

-  Planlegging av nye prosjekter mht metodevalg og beregning av kostnader.

-  Optimalisering av antistoffer og prober samt metodeutvikling og gjennomføring av prosjektene. 

-  Veiledning på lab av Bachelor, Master og PhD studenter

  • Eline Sol Garthsdatter Tylden, Andrè Berli Delgado, Marko Lukic, Line Moi, Lill-Tove Rasmussen Busund, Mona Irene Pedersen et al.:
    Roles of miR-20a-5p in breast cancer based on the clinical and multi-omic (CAMO) cohort and in vitro studies
    Scientific Reports 2024 ARKIV / DOI
  • Dagny Førde, Thomas Karsten Kilvær, Mona Irene Pedersen, Egil Støre Blix, Ilona Halva Urbarova, Erna-Elise Paulsen et al.:
    High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC
    Frontiers in Immunology 2024 ARKIV / DOI
  • Erna-Elise Paulsen, Sigve Andersen, Mehrdad Rakaee, Mona Irene Pedersen, Ana Paola Lombardi, Mette Pøhl et al.:
    Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
    Frontiers in Oncology 2023 ARKIV / DOI
  • Hallgeir Selven, Lill-Tove Rasmussen Busund, Sigve Andersen, Mona Irene Pedersen, Ana Paola Lombardi, Thomas Karsten Kilvær :
    High Expression of IRS-1, RUNX3 and SMAD4 Are Positive Prognostic Factors in Stage I–III Colon Cancer
    Cancers 2023 ARKIV / DOI
  • Mehrdad Rakaee, Sigve Andersen, K. Giannikou, Erna-Elise Paulsen, Thomas Karsten Kilvær, Lill-Tove Rasmussen Busund et al.:
    Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial
    Annals of Oncology 2023 ARKIV / DOI
  • Hallgeir Selven, Sigve Andersen, Mona Irene Pedersen, Ana Paola Lombardi, Lill-Tove Rasmussen Busund, Thomas Karsten Kilvær :
    High expression of miR-17-5p and miR-20a-5p predicts favorable disease-specific survival in stage I-III colon cancer
    Scientific Reports 2022 ARKIV / DOI
  • Einar Stikbakke, Tom Wilsgaard, Hege Sagstuen Haugnes, Mona Irene Pedersen, Tore Knutsen, Martin Støyten et al.:
    Expression of miR-24-1-5p in Tumor Tissue Influences Prostate Cancer Recurrence: The PROCA-life Study
    Cancers 2022 ARKIV / DOI
  • Maria Jenvin Støen, Sigve Andersen, Mehrdad Rakaee, Mona Irene Pedersen, Lise Martine Ingebriktsen, Roy M. Bremnes et al.:
    High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
    Scientific Reports 2021 ARKIV / DOI
  • Maria Jenvin Støen, Sigve Andersen, Mehrdad Rakaee, Mona I. Pedersen, Lise Martine Ingebriktsen, Tom Dønnem et al.:
    Overexpression of mir-20a-5p in tumor epithelium is an independent negative prognostic indicator in prostate cancer—a multi-institutional study
    Cancers 2021 ARKIV / DOI
  • Elin Richardsen, Sigve Andersen, Christian Melbø-Jørgensen, Mehrdad Rakaee, Nora Ness, Samer Al-Saad et al.:
    MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer
    Scientific Reports 2019 ARKIV / DOI
  • Elin Richardsen, Sigve Andersen, Samer Al-Saad, Mehrdad Rakaee, Yngve Nordby, Mona Irene Pedersen et al.:
    Low expression of miR-424-3p is highly correlated with clinical failure in prostate cancer
    Scientific Reports 2019 ARKIV / DOI
  • Mona Nystad, Vasilis Sitras, Cecilie Valborg Nordbakken, Mona Irene Pedersen, Ganesh Acharya :
    Laeverin Protein Expression in Normal and Preeclamptic Placentas using Tissue Microarray Analysis
    Acta Obstetricia et Gynecologica Scandinavica 2018 ARKIV / DOI
  • Kaja Konstanse Skjefstad, Charles Johannessen, Thea K.W. Grindstad, Thomas Karsten Kilvær, Erna Elise Paulsen, Mona Irene Pedersen et al.:
    A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer
    Scientific Reports 2018 ARKIV / DOI
  • Charles Johannessen, Line Moi, Yury Kiselev, Mona Irene Pedersen, Stig Manfred Dalen, Tonje Braaten et al.:
    Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer
    PLOS ONE 2017 ARKIV / DOI
  • Elin Richardsen, Sigve Andersen, Samer Al-Saad, Mehrdad Rakaee, Yngve Nordby, Mona Irene Pedersen et al.:
    Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort
    PLOS ONE 2017 ARKIV / DOI
  • Helge Stenvold, Tom Dønnem, Sigve Andersen, Samer Al-Saad, Andrey Yurjevich Valkov, Mona Irene Pedersen et al.:
    High tumor cell expression of microRNA-21 in node positive non-small cell lung cancer predicts a favorable clinical outcome
    BMC Clinical Pathology 2014 ARKIV / DOI
  • Georg Sager, Berit Bang, Mona Irene Pedersen, jarle Aarbakke :
    The human promyelocytic leukemia cell (HL-60 cell) ß-adrenergic receptor
    Journal of Leukocyte Biology 1988
  • Georg Sager, Berit Bang, Mona Irene Pedersen, jarle Aarbakke :
    ß-adrenergic receptors of normal, transformed and immature leuko¬cytes
    Humana Press 1987

    • The 50 latest publications is shown on this page. See all publications in Cristin here →
    MH øst L8.136


    Click for bigger map